4//SEC Filing
Jansen Valerie Malyvanh 4
Accession 0001415889-24-004403
CIK 0001783032other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:02 PM ET
Size
8.3 KB
Accession
0001415889-24-004403
Insider Transaction Report
Form 4
Jansen Valerie Malyvanh
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-02-15+225,000→ 225,000 totalExercise: $2.77Exp: 2034-02-14→ Common Stock (225,000 underlying) - Award
Restricted Stock Unit
2024-02-15+70,000→ 70,000 total→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]The stock option vests as to 25% of the total shares on February 15, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the RSUs vest on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F4]The RSUs do not expire; they either vest or are canceled prior to the vesting date.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
Related Parties
1- filerCIK 0001889716
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 5:02 PM ET
- Size
- 8.3 KB